In 2014, with the initiative of Professor Constantinos Pangalos, Genomis Ltd (UK) was founded in England with the assistance of a group of geneticists to study and design new pioneering genomic tests with specific clinical applications. InterGenetics therefore has a close collaboration with Genomis to perform all genomic examinations performed at our Center and particularly new innovative tests such as:
- test Progenomis® aimed at future parents
- test Fertilitis® for the investigation of male or female infertility
- test Fetalis® performed prenatally in fetuses with various ultrasound abnormalities
- test FetalSafe® for comprehensive prenatal testing, as well as its variation
- test FetalSafe® Plus, that also includes the prenatal molecular karyotype
- test CarrierFree® aimed for carrier detection of severe genetic disorders
- test DonoSafe® aimed for safe gamete donation
- test Preventomis® aimed at timely disease prevention in adults
as well as many other NGS- based genomic tests with wide clinical applications